EARNINGS PER SHARE - Additional Information (Details) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock, shares outstanding (in shares)	191,005,940	186,235,818
Common stock, shares issued (in shares)	191,005,940	186,235,818
Warrants outstanding (in shares)	9,496
Exercise price at grant date (in dollars per share)	$ 23.76
Subordinate Voting Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of subordinate voting (in shares)	1
Not Contractually Issuable Until the Earlier of December 1, 2031 | Restricted share units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock, reserved for future issuance (in shares)	100,000